MATTHEW HILLIS: Open Payments
NPI 1871184911 · GUTHRIE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,801 in 264 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,846 · 2025 $4,801
Food & beverage: $4,724Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,056 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $632 |
| PFIZER INC. | 23 | $464 |
| Janssen Biotech, Inc. | 22 | $458 |
| Regeneron Healthcare Solutions, Inc. | 12 | $324 |
| Lilly USA, LLC | 13 | $310 |
| Madrigal Pharmaceuticals | 13 | $296 |
| Ipsen Biopharmaceuticals, Inc | 16 | $259 |
| GENZYME CORPORATION | 13 | $204 |
| Aimmune Therapeutics, Inc. | 9 | $140 |
Products named: DUPIXENT, ENTYVIO, RINVOQ, TREMFYA, VELSIPITY, REZDIFFRA, OMVOH, IQIRVO.
Industry payments across OK — which companies pay providers there.
